statistiche ricercatore

Continente	#
NA - Nord America	514
AS - Asia	437
EU - Europa	324
SA - Sud America	50
Continente sconosciuto - Info sul continente non disponibili	32
AF - Africa	30
Totale	1.387

Nazione	#
US - Stati Uniti d'America	497
SG - Singapore	157
IT - Italia	117
CN - Cina	79
VN - Vietnam	69
IN - India	67
DE - Germania	43
IE - Irlanda	43
BR - Brasile	37
SE - Svezia	29
GB - Regno Unito	24
HK - Hong Kong	22
ZA - Sudafrica	15
FR - Francia	14
UA - Ucraina	12
NL - Olanda	8
BD - Bangladesh	7
CA - Canada	7
CI - Costa d'Avorio	7
PL - Polonia	7
AR - Argentina	6
ID - Indonesia	6
MX - Messico	5
TR - Turchia	5
ES - Italia	4
FI - Finlandia	4
PK - Pakistan	4
AT - Austria	3
CZ - Repubblica Ceca	3
EG - Egitto	3
MY - Malesia	3
RU - Federazione Russa	3
BE - Belgio	2
CH - Svizzera	2
IQ - Iraq	2
JM - Giamaica	2
JP - Giappone	2
LB - Libano	2
PY - Paraguay	2
SA - Arabia Saudita	2
TH - Thailandia	2
TT - Trinidad e Tobago	2
TW - Taiwan	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
BH - Bahrain	1
BO - Bolivia	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
DK - Danimarca	1
EC - Ecuador	1
EU - Europa	1
GA - Gabon	1
JO - Giordania	1
KE - Kenya	1
MA - Marocco	1
MC - Monaco	1
NP - Nepal	1
PE - Perù	1
PH - Filippine	1
PS - Palestinian Territory	1
RO - Romania	1
RS - Serbia	1
SC - Seychelles	1
SK - Slovacchia (Repubblica Slovacca)	1
TN - Tunisia	1
Totale	1.356

Nome	#
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD	254
Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation	214
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury	187
Multi-Target CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach	186
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling	167
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases	162
Su1816–Protection by Ccr6 Blockade in a Murine Model of Crohn’s Disease	106
UNIPR1331: SMALL EPH/EPHRIN ANTAGONIST BENEFICIAL IN INTESTINAL INFLAMMATION BY INTERFERING WITH TYPE-B SIGNALLING	105
In vivo and in vitro modulation of the Eph/ephrin System as a key element in intestinal inflammation	6
Totale	1.387

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	135	0	4	13	49	24	9	7	6	5	6	2	10
2022/2023	181	11	11	13	12	23	19	5	18	54	5	6	4
2023/2024	75	4	5	4	3	7	13	5	9	3	3	5	14
2024/2025	264	15	12	13	14	33	27	16	19	33	21	19	42
2025/2026	522	58	41	49	33	100	31	44	22	60	47	23	14
2026/2027	15	7	8	0	0	0	0	0	0	0	0	0	0
Totale													1.387